Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Sell
7,271
-214
-3% -$29.6K 1% 25
2026
Q2
$962K Sell
7,485
-604
-7% -$70.7K 0.89% 33
2026
Q1
$973K Sell
8,089
-2,055
-20% -$237K 1.02% 27
2025
Q4
$1.07M Buy
+10,144
New +$952K 1.13% 24

Other funds holding MRK

Split Creek Capital's MRK Position: Q3 2026 in Review

Split Creek Capital reduced its Merck (MRK) stake by 2.9% in Q3 2026, selling an estimated $29.6K and leaving 7,271 shares worth $1.06M. The position accounts for 1% of the portfolio, ranked #25.

Split Creek Capital first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.07M in Q4 2025. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Split Creek Capital held 7,271 shares of Merck worth $1.06M as of Q3 2026.
  • Split Creek Capital sold 214 Merck shares in Q3 2026, an estimated $29.6K.
  • Merck made up 1% of Split Creek Capital's portfolio in Q3 2026, its #25 holding.
  • Split Creek Capital first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • Split Creek Capital's Merck position peaked at $1.07M in Q4 2025.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.